Tidal Investments’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $710K | Sell |
312,850
-40,990
| -12% | -$93K | ﹤0.01% | 1154 |
|
|
2025
Q1 | $225K | Sell |
353,840
-28,689
| -7% | -$18.2K | ﹤0.01% | 1617 |
|
|
2024
Q4 | $394K | Buy |
382,529
+136,528
| +55% | +$141K | ﹤0.01% | 1461 |
|
|
2024
Q3 | $290K | Sell |
246,001
-12,000
| -5% | -$14.2K | ﹤0.01% | 1583 |
|
|
2024
Q2 | $315K | Sell |
258,001
-30,100
| -10% | -$36.7K | ﹤0.01% | 1488 |
|
|
2024
Q1 | $631K | Sell |
288,101
-18,006
| -6% | -$39.4K | 0.01% | 1073 |
|
|
2023
Q4 | $474K | Sell |
306,107
-12,004
| -4% | -$18.6K | 0.01% | 952 |
|
|
2023
Q3 | $410K | Hold |
318,111
| – | – | 0.01% | 934 |
|
|
2023
Q2 | $547K | Hold |
318,111
| – | – | 0.02% | 774 |
|
|
2023
Q1 | $480K | Sell |
318,111
-27,794
| -8% | -$41.9K | 0.02% | 780 |
|
|
2022
Q4 | $553K | Buy |
345,905
+34,590
| +11% | +$55.3K | 0.02% | 635 |
|
|
2022
Q3 | $451K | Buy |
311,315
+103,543
| +50% | +$150K | 0.02% | 598 |
|
|
2022
Q2 | $380K | Buy |
+207,772
| New | +$380K | 0.01% | 693 |
|